National Bank of Canada’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

National Bank of Canada’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-133,000	Closed	-$17.5M	–	3272
2025 Q1	$17.5M	Buy	+133,000	New	+$16.6M	0.02%	556

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

National Bank of Canada's ITCI Position: Q2 2025 in Review

National Bank of Canada sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 133,000 shares — an estimated $17.5M sold.

National Bank of Canada first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $17.5M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

National Bank of Canada reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
National Bank of Canada sold 133,000 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $17.5M.
National Bank of Canada first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
National Bank of Canada's Intra-Cellular Therapies Inc. position peaked at $17.5M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on National Bank of Canada's 13F filing for Q2 2025, filed 13 Aug 2025.